Xenon Pharmaceuticals Inc Sustainability Reports
Xenon Pharmaceuticals Inc. is a neuroscience-focused biopharmaceutical company engaged in discovering and developing innovative therapeutics for neurological and psychiatric disorders. Its clinical pipeline primarily focuses on areas of unmet medical need, such as epilepsy and depression.
Sector: Manufacturing
Country: Canada
Exchange: Nasdaq
LEI: 549300XV44Q9Z1MIPQ03
FIGI: BBG002VBMLS5
11 reports from 2014 to 2025